360Dx

JPM Healthcare Day Two: 10x Genomics, Foundation Med, Quidel, Hologic, LabCorp, Nanostring, Bio-Rad

Jan 11, 2017

SAN FRANCISCO (GenomeWeb) – The 35th Annual JP Morgan Healthcare Conference continued this week with several life science research tools and diagnostic firms making presentations to investors and other attendees.

The following are summaries of presentations and breakout sessions on Monday and Tuesday by 10x Genomics, Foundation Medicine, Quidel, Hologic, LabCorp, Nanostring Technologies, and Bio-Rad Laboratories.

10x Genomics

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

Menu

JPM Healthcare Day Two: 10x Genomics, Foundation Med, Quidel, Hologic, LabCorp, Nanostring, Bio-Rad

To read the full story....

Breaking News

FDA Adds At-Home Self-Collection Template to SARS-CoV-2 Emergency Use Authorization Guidance

BTIG Initiates Coverage of Fulgent Genetics

Tangen Biosciences, LabWare Partner on Point-of-Care Coronavirus Kit

Progenity Files for IPO, Seeks to Raise up to $100M

LetsGetChecked At-Home Molecular SARS-CoV-2 Test Nabs FDA Emergency Use Authorization

OraSure Technologies to Acquire HIV Drug Adherence Test Developer UrSure

Featured White Papers

COVID-19 Testing, Treatment and Future Outlook

Diagnostic Challenges in Cancer Immunotherapy: An Expert Panel Discussion

What's Popular?

LetsGetChecked At-Home Molecular SARS-CoV-2 Test Nabs FDA Emergency Use Authorization

AMP SARS-CoV-2 Molecular Dx Survey Shows Supply Chain Issues Hampered Ramp Up of Testing

FDA Releases Reference Panel for Coronavirus Test Developers

Progenity Files for IPO, Seeks to Raise up to $100M

With Low-Cost SARS-CoV-2 Assay, FYR Diagnostics Looks to Bypass Equipment Bottlenecks

Sponsorships